MaxCyte, Inc. - Common Stock (NQ:MXCT)
Price and Volume
Detailed Quote| Volume | 504,000 |
| Open | 1.080 |
| Bid (Size) | 1.100 (600) |
| Ask (Size) | 1.110 (1,700) |
| Prev. Close | 1.070 |
| Today's Range | 1.080 - 1.120 |
| 52wk Range | 0.6434 - 2.190 |
| Shares Outstanding | 105,482,558 |
| Dividend Yield | N/A |
Top News
More News
Performance
More News
Read More
MaxCyte Q1 Earnings Call Highlights ↗
May 12, 2026
Earnings Scheduled For November 12, 2025 ↗
November 12, 2025
Earnings Scheduled For November 5, 2025 ↗
November 05, 2025
MaxCyte (MXCT) Q4 2025 Earnings Call Transcript ↗
March 24, 2026
MaxCyte Appoints Parmeet Ahuja as Chief Financial Officer
March 23, 2026
MaxCyte Announces Planned CFO Transition in 2026
November 12, 2025
Insights into MaxCyte's Upcoming Earnings ↗
November 11, 2025
Frequently Asked Questions
Is MaxCyte, Inc. - Common Stock publicly traded?
Yes, MaxCyte, Inc. - Common Stock is publicly traded.
What exchange does MaxCyte, Inc. - Common Stock trade on?
MaxCyte, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for MaxCyte, Inc. - Common Stock?
The ticker symbol for MaxCyte, Inc. - Common Stock is MXCT on the Nasdaq Stock Market
What is the current price of MaxCyte, Inc. - Common Stock?
The current price of MaxCyte, Inc. - Common Stock is 1.105
When was MaxCyte, Inc. - Common Stock last traded?
The last trade of MaxCyte, Inc. - Common Stock was at 08/06/26 01:33 PM ET
What is the market capitalization of MaxCyte, Inc. - Common Stock?
The market capitalization of MaxCyte, Inc. - Common Stock is 116.56M
How many shares of MaxCyte, Inc. - Common Stock are outstanding?
MaxCyte, Inc. - Common Stock has 117M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
|
|
|